FAM109A Inhibitors
FAM109A inhibitors largely focus on the modulation of cellular trafficking and endosomal pathways. Brefeldin A and SecinH3 are chemicals that target ARF activation and cytohesin activity, respectively. Given that these proteins have a pronounced role in vesicular trafficking and endosome dynamics, their inhibitors can affect FAM109A, which operates within these pathways. Similarly, ML141, ZCL278, EHT 1864, and NSC23766 target small GTPases like Cdc42 and Rac, which govern endocytosis and vesicular traffic. By modulating the activity of these GTPases, the endosomal role of FAM109A can be influenced.
The role of phosphoinositides in endosomal sorting and maturation is pivotal. Therefore, compounds like LY294002 and Wortmannin, which inhibit PI3K, can impact vesicle formation and trafficking. Such changes in cellular dynamics can indirectly modulate the function of FAM109A. Dynasore targets dynamin, vital for vesicle scission from membranes. Any disruption in this process can have downstream effects on proteins associated with endosomes, including FAM109A. Finally, TBCA, IPA-3, and Manumycin A, which target TBK1, PAK1, and Ras respectively, are representatives of the broader approach of modulating cellular signaling and trafficking.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts ARF1 activation, which can affect endosomal trafficking and, indirectly, FAM109A. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
Affects cytohesin activity and can impact ARF GTPases, indirectly modulating endosomal dynamics and potentially FAM109A's role. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Cdc42 inhibitor; given the role of Cdc42 in endosomal dynamics, it can indirectly influence FAM109A function. | ||||||
ZCL278 | 587841-73-4 | sc-507369 | 10 mg | $115.00 | ||
Cdc42-specific inhibitor that can modulate endocytosis and endosomal pathways, thus potentially impacting FAM109A. | ||||||
EHT 1864 | 754240-09-0 | sc-361175 sc-361175A | 10 mg 50 mg | $213.00 $889.00 | 12 | |
Rac family GTPase inhibitor, can influence cellular trafficking and might affect FAM109A's function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Inhibits dynamin, a key protein in vesicle scission. By affecting endocytosis, it can indirectly modulate FAM109A's activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can affect endosomal trafficking and phagocytosis, potentially influencing FAM109A. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, disrupting vesicular trafficking and thus might have an impact on FAM109A function. | ||||||
Casein Kinase II Inhibitor III, TBCA | 934358-00-6 | sc-203869 | 5 mg | $197.00 | 10 | |
TBK1 inhibitor; given TBK1's role in endosomal pathways, it can indirectly modulate FAM109A. | ||||||
IPA 3 | 42521-82-4 | sc-204016 sc-204016A | 5 mg 50 mg | $94.00 $458.00 | 6 | |
PAK1 inhibitor, which can affect cytoskeletal dynamics and endosomal processes, indirectly influencing FAM109A. | ||||||